This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Ilan Tsarfaty: Innovator in Breast Cancer Research
Introduction
Ilan Tsarfaty is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of cancer research, particularly in understanding breast cancer progression. His innovative work has the potential to impact the lives of many patients facing this challenging disease.
Latest Patents
Ilan Tsarfaty holds a patent for a method related to the met proto-oncogene. This method is designed for predicting breast tumor metastasis by determining the amount of met protein in tumor tissue relative to normal breast duct tissue. His patent represents a crucial advancement in the early detection and treatment of breast cancer.
Career Highlights
Tsarfaty is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution allows him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include James H. Resau and Iafa Keydar. Their collaborative efforts enhance the research environment and foster innovation in cancer studies.
Conclusion
Ilan Tsarfaty's contributions to breast cancer research through his patent and work at the National Institutes of Health highlight his commitment to improving patient outcomes. His innovative methods pave the way for future advancements in cancer treatment and detection.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile